Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · Real-Time Price · USD
101.20
-0.09 (-0.09%)
At close: Dec 1, 2025, 4:00 PM EST
101.02
-0.18 (-0.18%)
After-hours: Dec 1, 2025, 4:35 PM EST
Exact Sciences Stock Forecast
Stock Price Forecast
The 16 analysts that cover Exact Sciences stock have a consensus rating of "Buy" and an average price target of $76.38, which forecasts a -24.53% decrease in the stock price over the next year. The lowest target is $46 and the highest is $105.
Price Target: $76.38 (-24.53%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Exact Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 11 | 5 |
| Buy | 7 | 7 | 7 | 7 | 7 | 5 |
| Hold | 2 | 2 | 4 | 4 | 3 | 10 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 20 | 22 | 22 | 21 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $85 → $105 | Strong Buy → Hold | Downgrades | $85 → $105 | +3.75% | Nov 25, 2025 |
| Benchmark | Benchmark | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 24, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $90 → $105 | Strong Buy → Hold | Downgrades | $90 → $105 | +3.75% | Nov 24, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $85 → $105 | Buy → Hold | Downgrades | $85 → $105 | +3.75% | Nov 21, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 21, 2025 |
Financial Forecast
Revenue This Year
3.22B
from 2.76B
Increased by 16.68%
Revenue Next Year
3.62B
from 3.22B
Increased by 12.36%
EPS This Year
-0.65
from -5.59
EPS Next Year
0.42
from -0.65
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.3B | 3.8B | |||
| Avg | 3.2B | 3.6B | |||
| Low | 3.1B | 3.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.7% | 19.4% | |||
| Avg | 16.7% | 12.4% | |||
| Low | 11.8% | 3.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.48 | 0.65 | |||
| Avg | -0.65 | 0.42 | |||
| Low | -0.81 | 0.14 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.